Results 61 to 70 of about 29,446 (242)
Vitiligo is a noncontagious autoimmune skin depigmenting disease. Regulatory T cells (Tregs) play a key role in maintaining peripheral tolerance; however, Tregs’ number, suppressive function, and associated suppressive molecules (FOXP3, IL-10, and TGF-β)
Prashant S. Giri +2 more
doaj +1 more source
Startups Driving Artificial Intelligence Into Clinical Dermatology
ABSTRACT Artificial intelligence (AI) is rapidly transitioning from innovation to routine clinical application in dermatology. This review examines how AI‐enabled technologies are being developed and integrated across diverse clinical purposes and workflows.
Dominique Du Crest +10 more
wiley +1 more source
Vitiligo and social acceptance [PDF]
Reza Bidaki,1 Niloofar Majidi,2 Amir Moghadam Ahmadi,3 Hamid Bakhshi,4 Rezvan Sadr Mohammadi,5 Seyed-Ali Mostafavi,6 Mohammad Kazemi Arababadi,7 Maryam Hadavi,8 Afshin Mirzaei9 1Research Center of Addiction and Behavioral Sciences, Diabetes Research ...
Sadr Mohammadi R +8 more
core
Vitiligo treatment: a literature review [PDF]
Vitiligo is a chronic disease characterized by the focal damage of melanocytes, which results in formation of discoloured spots on the skin. This disease affects from 0.5% to even 4% of the general population and the first symptoms appear before the ...
Adrianna P. Pyrek +3 more
core +1 more source
Refractory Eczema as a Presenting Feature of Common Variable Immunodeficiency
ABSTRACT Common variable immunodeficiency (CVID) is the most prevalent symptomatic inborn error of immunity (IEI) in adults. It presents with recurrent infections and non‐infectious complications, including autoimmunity, lymphoproliferation and dermatitis.
Mercedes Sanchez‐Diaz +2 more
wiley +1 more source
Recalcitrant Eyelid Lupus Treated With Topical Ruxolitinib
ABSTRACT Lupus of the eyelids, or lupus blepharitis, is a rare and localized form of chronic cutaneous lupus. The use of topical corticosteroids is limited in this sensitive area due to the risk of adverse events. We present a case of eyelid lupus, with histological confirmation, resistant to multiple lines of treatment, successfully treated with ...
Clémence Bertold +6 more
wiley +1 more source
An economic evaluation of the randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo (the HI-Light Vitiligo Trial) [PDF]
BACKGROUND: Economic evidence for vitiligo treatments is absent., OBJECTIVES: To determine the cost-effectiveness of (i) handheld narrowband ultraviolet B (NB-UVB) and (ii) a combination of topical corticosteroid (TCS) and NB-UVB compared with TCS alone ...
Rogers, Andy +3 more
core +1 more source
Prevalence of Vitiligo in the Tobruk District, Libya
Vitiligo, a common depigmenting skin disorder, has an estimated prevalence of 0.5–2% of the population worldwide. The disease is characterized by the selective loss of melanocytes which results in typical non scaly, chalky-white macules. In recent
Mohammed Elsady +6 more
doaj +1 more source
LC‐OCT Features in Vitiligo: A Preliminary Report
ABSTRACT Background Vitiligo is a chronic depigmenting disorder characterized by the selective loss of melanocytes, leading to the progressive development of hypopigmented macules and patches. Line‐field confocal optical coherence tomography (LC‐OCT) is a novel imaging technique that combines the advantages of optical coherence tomography (OCT) and ...
Gerardo Palmisano +6 more
wiley +1 more source
Current and emerging therapy for the management of vitiligo [PDF]
Alicia Cecile Borderé, Jo Lambert, Nanny van GeelUniversity Hospital of Ghent, Department of Dermatology, Ghent, BelgiumAbstract: Vitiligo is an acquired cutaneous disorder of pigmentation, with an incidence of 0.5% to 2% worldwide.
Lambert, Jo +8 more
core

